Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The MCL35 gene expression proliferation assay predicts high-risk MCL patients in a Norwegian cohort of younger patients given intensive first line therapy.
Holte H, Beiske K, Boyle M, Trøen G, Blaker YN, Myklebust J, Kvaløy S, Rosenwald A, Lingjaerde OC, Rimsza LM, Smeland EB, Scott DW, Kolstad A. Holte H, et al. Among authors: beiske k. Br J Haematol. 2018 Oct;183(2):225-234. doi: 10.1111/bjh.15518. Epub 2018 Aug 6. Br J Haematol. 2018. PMID: 30080252 Free PMC article. Clinical Trial.
Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series.
Wise JF, Nakken S, Steen CB, Vodák D, Trøen G, Johannessen B, Lingjærde OC, Hilden V, Blaker YN, Bai B, Aasheim LB, Pasanen A, Lorenz S, Sveen A, Lothe RA, Myklebost O, Leppä S, Meza-Zepeda LA, Beiske K, Lawrence MS, Hovig E, Myklebust JH, Smeland EB, Holte H. Wise JF, et al. Among authors: beiske k. Blood Adv. 2020 May 12;4(9):1859-1866. doi: 10.1182/bloodadvances.2019001325. Blood Adv. 2020. PMID: 32374878 Free PMC article.
Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis.
Leppä S, Jørgensen J, Tierens A, Meriranta L, Østlie I, de Nully Brown P, Fagerli UM, Larsen TS, Mannisto S, Munksgaard L, Maisenhölder M, Vasala K, Meyer P, Jerkeman M, Björkholm M, Fluge Ø, Jyrkkiö S, Liestøl K, Ralfkiaer E, Spetalen S, Beiske K, Karjalainen-Lindsberg ML, Holte H. Leppä S, et al. Among authors: beiske k. Blood Adv. 2020 May 12;4(9):1906-1915. doi: 10.1182/bloodadvances.2020001518. Blood Adv. 2020. PMID: 32380536 Free PMC article. Clinical Trial.
The DLBCL90 gene-expression assay identifies double-hit lymphomas with high sensitivity in patients from two phase II clinical trials with high-risk diffuse large B-cell lymphoma.
Isaksen KT, Beiske K, Smeland EB, Jørgensen J, Brodtkorb M, Myklebust JH, Jerkeman M, Meriranta L, Karjalainen-Lindsberg ML, Leppä S, Scott DW, Holte H, Blaker YN. Isaksen KT, et al. Among authors: beiske k. EJHaem. 2020 Dec 5;2(1):104-108. doi: 10.1002/jha2.109. eCollection 2021 Feb. EJHaem. 2020. PMID: 35846101 Free PMC article. No abstract available.
Mantle cell lymphoma with features of marginal-zone lymphoma.
Randen U, Yri OE, Tierens A, Heim S, Beiske K, Delabie J. Randen U, et al. Among authors: beiske k. J Hematop. 2011 Mar 2;4(1):7-11. doi: 10.1007/s12308-011-0084-x. eCollection 2011 Mar. J Hematop. 2011. PMID: 25089161 Free PMC article.
The role of surgery in intracranial PCNSL.
Jahr G, Da Broi M, Holte H Jr, Beiske K, Meling TR. Jahr G, et al. Among authors: beiske k. Neurosurg Rev. 2018 Oct;41(4):1037-1044. doi: 10.1007/s10143-018-0946-0. Epub 2018 Jan 27. Neurosurg Rev. 2018. PMID: 29383600
141 results